Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Patent CN113735867B introduces mild room temperature synthesis of chiral indolo-oxa compounds with high yield and enantioselectivity offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing
Novel chiral indolinopyrrole synthesis via phosphoric acid catalysis achieves high enantioselectivity and scalability, enabling cost-effective API intermediate production for oncology therapeutics.
Patent CN116768812A introduces a novel catalytic method for multi-substituted dihydrooxazoles with high yield and simplified process flow enabling significant cost reduction and enhanced supply chain reliability for flavor and agrochemical applications.
Breakthrough chiral phosphoric acid catalyst with spiro-bis-dihydrobenzothiole skeleton enables high-enantioselectivity asymmetric synthesis for pharmaceutical intermediates, offering reliable supply chain and cost reduction.
Novel chiral phosphoric acid-catalyzed synthesis achieves high enantioselectivity and yield for N-N axis pyrrole derivatives, enabling cost-effective pharmaceutical production with enhanced supply chain reliability.
Patent CN114478245A enables high-purity chiral intermediates with streamlined manufacturing and enhanced supply chain resilience for pharmaceutical applications.
Patent CN113880781B enables high-purity triazole synthesis using biomass glucose with mild conditions and scalable manufacturing advantages.
Novel one-pot Lewis acid catalysis achieves >90% yield for indaneamine, enabling sustainable agrochemical manufacturing with reduced waste and reliable supply chain solutions.
Patent CN119060057B introduces a mild chiral phosphoric acid-catalyzed synthesis of indolocyclopentanes with high yield and selectivity, enabling scalable production and significant cost savings for pharmaceutical intermediates.
Patent CN113527177B introduces a safe catalytic route eliminating explosive reagents for gem-difluoroolefin intermediates enabling enhanced supply chain reliability and significant cost reduction in pharmaceutical manufacturing.
Patent CN113527177B enables scalable production of high-purity fluorinated intermediates through safe synthesis without explosive reagents offering significant cost reduction in pharmaceutical manufacturing supply chains
Breakthrough chiral indoxazinone synthesis with high enantioselectivity enables cost-effective manufacturing and reliable supply chain for oncology drug development.
Innovative chiral phosphoric acid catalyzed process delivers high enantioselectivity and yield for pharmaceutical intermediates ensuring scalable cost-effective production with stringent purity standards
Patent CN118878452B enables high-yield synthesis under mild conditions with significant cost savings for reliable pharmaceutical intermediate supply chains.
Patent CN102040561B introduces a green synthesis method using acidic ionic liquids for benzotriazole UV absorbers enabling high-yield production with reduced waste and simplified supply chain management.
Novel chiral pyrrole synthesis method enables high-yield production with exceptional enantioselectivity, enhancing pharmaceutical supply chain reliability and cost efficiency.
Patent CN116199614B enables high-yield synthesis of chiral catalysts with up to 98% ee, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN119874717B enables mild synthesis of high-purity antitumor intermediates with scalable production, offering cost-effective supply chain solutions for pharmaceutical manufacturers.
Novel Lewis acid-catalyzed method enables high-yield production of bioactive indole-piperidine compounds under mild conditions enhancing supply chain reliability and cost efficiency for pharmaceutical intermediates